NewsRelease
BiotechSupport Group to exhibit at the 66th Conference on Mass Spectrometryand Allied Topics June 3 - 7, 2018 in San Diego, CA
MONMOUTHJUNCTION, NJ,May10, 2018 -- BiotechSupport Group will exhibit at the annual American Society for MassSpectrometry (ASMS) Conference, June 3-7, 2018 in San Diego, CA. Theconference highlights the most recent advancements in MassSpectrometry technology applications and expects an attendance of6,500 scientists and 3,000 presentations as talks and posters.
Featuredat our Booth 405, will be consumable sample prep products forproteome enrichment, and on-bead digestion for rapid and streamlinedworkflows to improve quantification of label and label-freeproteomics. In addition, there will be two technical poster reportsdescribing the advantageous use of our products for serumapplications:
Thefirst is entitled “Profiling low abundant species in sera withcoupled use of an innovative Albumin depletion sample preparation andMALDI-MS”, co-authored with collaborators from Ascend Diagnostics.
Thesecond is entitled “Stroma Liquid Biopsy – Pan-CancerDysregulation of the Serum Proteome”, co-authored withcollaborators from the Rutgers Proteomics Center.
Bothposters will be presented on Monday June 4. For more information about our Sample Prep Mass Spectrometry Products click here!
“Wewill be highlighting our many successes over the past 6 months atthis Conference. This includes our patent application on our cancerbiomarker panel, our most recent data on our consumable proteomicsample prep product AlbuVoid™ On-Bead LC-MS, and coupled use of oursample prep to a new downstream versatile platform – MALDI-MS. Itis very exciting to share these developments with an industry groupat the forefront of life science research”, states Dr. Swapan Roy,Ph.D., President and Founder of Biotech Support Group.
AboutBiotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, HemogloBind™ and HemoVoid™ for hemoglobin removal,and NuGel™ for functional proteomics. From these innovations, thecompany has acquired knowledgebase and biomarker intellectualproperty assets that support discoveries of protein markers fromblood, with special emphasis on early detection and personalizedmedical decisions for cancer patients. For more information, go tohttp://www.biotechsupportgroup.com
Contact:
MatthewKuruc 732-274-2866
[email protected]
